Travere Therapeutics Inc at JPMorgan Healthcare Conference Transcript
&-
All right. Let's go ahead and get started. Welcome, everyone, to the 42nd Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Priyanka Grover, Laura Hall, and Malcolm Cunha. Our next presenting company is Travere and presenting on behalf of the company, we have Eric Dube.
Thank you very much Anupam, and thank you, JPMorgan for hosting us. I'm Eric Dube, President and CEO of Travere Therapeutics, and I will start with the formal information or forward-looking statements you can find on our website as well as additional information about our company and our pipeline company that is focused exclusively in rare disease, and we focus on developing and delivering medicines for communities in the rare and rare community that have very little to no options therapeutically. And we're very pleased to be able to provide hope for patients, particularly within
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |